13F-HR filed by BAKER BROS. ADVISORS LP
BAKER BROS. ADVISORS LP filed this 13F-HR for the quarter ended 2026-09-30, accepted by EDGAR 2026-11-16 21:11:34 UTC, with 80 holding rows worth $21,044,442,318.
- Accession
- 0001104659-26-128308
- Filer
- CIK 1263508
- Filed
- 2026-11-16
- Accepted by EDGAR
- Ingested
- Source
- EDGAR daily index
13F report for Q3 2026
A holdings report, 80 entries on the cover page, a total value of $21,044,442,318 stated on the cover page (in dollars after the unit check, H1), rows summing to $21,044,442,318 with VALUE read as dollars as filed, 13F file number 028-10519. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| INCYTE CORP COM | 45337C102 | Stock | 30,762,652 | $3,733,047,820 | dollars as filed | |
| BEONE MEDICINES LTD SPONSORED ADS | 07725L102 | ADR | 8,832,335 | $3,232,104,670 | dollars as filed | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 10,637,318 | $2,183,415,893 | dollars as filed | |
| KODIAK SCIENCES INC | 50015M109 | COM | 21,860,941 | $2,072,417,207 | dollars as filed | |
| MADRIGAL PHARMACEUTICALS INC COM | 558868105 | Stock | 2,143,131 | $1,080,052,299 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 8,796,111 | $1,003,988,110 | dollars as filed | |
| KYMERA THERAPEUTICS INC | 501575104 | COM | 8,657,242 | $967,793,083 | dollars as filed | |
| ACADIA PHARMACEUTICALS INC | 004225108 | COM | 42,912,904 | $864,695,016 | dollars as filed | |
| GRAIL INC | 384747101 | COM | 4,028,614 | $564,489,394 | dollars as filed | |
| SUMMIT THERAPEUTICS INC | 86627T108 | COM | 32,786,348 | $554,417,145 | dollars as filed | |
| RHYTHM PHARMACEUTICALS INC | 76243J105 | COM | 5,604,483 | $533,630,849 | dollars as filed | |
| PRAXIS PRECISION MEDICINES I | 74006W207 | COM NEW | 1,753,198 | $510,583,854 | dollars as filed | |
| ABCELLERA BIOLOGICS INC COM | 00288U106 | Stock | 33,012,139 | $481,647,108 | dollars as filed | |
| ALKERMES PLC | G01767105 | SHS | 10,012,267 | $405,697,059 | dollars as filed | |
| CELCUITY INC | 15102K100 | COM | 4,815,792 | $382,951,780 | dollars as filed | |
| KINIKSA PHARMACEUTICALS INTL P ORD SHS CL A | G52694109 | Stock | 2,834,643 | $211,492,714 | dollars as filed | |
| IDEAYA BIOSCIENCES INC COM | 45166A102 | Stock | 5,010,030 | $192,485,353 | dollars as filed | |
| EDGEWISE THERAPEUTICS INC | 28036F105 | COM | 3,701,719 | $150,289,791 | dollars as filed | |
| REPLIMUNE GROUP INC | 76029N106 | COMMON STOCK | 11,045,336 | $146,240,249 | dollars as filed | |
| ROIVANT SCIENCES LTD | G76279101 | SHS | 3,660,352 | $133,859,073 | dollars as filed | |
| ARROWHEAD PHARMACEUTICALS IN | 04280A100 | COM | 1,709,053 | $111,857,519 | dollars as filed | |
| NURIX THERAPEUTICS INC | 67080M103 | COMMON STOCK | 4,658,556 | $110,454,363 | dollars as filed | |
| IMMUNOVANT INC | 45258J102 | COM | 2,770,377 | $93,583,335 | dollars as filed | |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 2,564,984 | $83,131,131 | dollars as filed | |
| DENALI THERAPEUTICS INC COM | 24823R105 | Stock | 3,734,336 | $77,188,725 | dollars as filed | |
| DIANTHUS THERAPEUTICS INC | 252828108 | COM | 852,164 | $75,033,040 | dollars as filed | |
| CELCUITY INC | 15102KAA8 | NOTE 2.750% 8/0 | 30,750,000 | $55,457,225 | dollars as filed | principal |
| RAPPORT THERAPEUTICS INC COM | 75383L102 | Stock | 1,547,090 | $51,982,224 | dollars as filed | |
| MONTE ROSA THERAPEUTICS INC | 61225M102 | COM | 4,345,736 | $51,844,630 | dollars as filed | |
| RELAY THERAPEUTICS INC COM | 75943R102 | Stock | 2,826,783 | $51,023,433 | dollars as filed | |
| IONIS PHARMACEUTICALS INC COM | 462222100 | Stock | 1,023,864 | $45,715,528 | dollars as filed | |
| STRUCTURE THERAPEUTICS INC COMP | 86366E106 | EQUITY | 1,432,529 | $44,795,182 | dollars as filed | |
| ENLIVEN THERAPEUTICS INC COM | 29337E102 | Stock | 905,191 | $41,493,955 | dollars as filed | |
| BICYCLE THERAPEUTICS PLC-ADR | 088786108 | SPONSORED ADS | 10,885,357 | $40,058,114 | dollars as filed | |
| PRELUDE THERAPEUTICS INC | 74065P101 | CMN | 10,123,824 | $39,584,152 | dollars as filed | |
| MIRUM PHARMACEUTICALS INC | 604749101 | COM | 445,975 | $38,121,943 | dollars as filed | |
| DESIGN THERAPEUTICS INC | 25056L103 | COM | 2,988,144 | $37,560,970 | dollars as filed | |
| IMMATICS N.V | N44445109 | SHS | 4,256,682 | $37,373,668 | dollars as filed | |
| STOKE THERAPEUTICS INC | 86150R107 | COM | 1,313,999 | $34,163,974 | dollars as filed | |
| ENTRADA THERAPEUTICS INC COM | 29384C108 | Stock | 5,072,730 | $32,211,836 | dollars as filed | |
| NEUROGENE INC | 64135M105 | COMMON STOCK | 991,691 | $27,588,844 | dollars as filed | |
| XENCOR INC | 98401F105 | COMMON STOCK | 1,102,106 | $27,497,545 | dollars as filed | |
| FAETH THERAPEUTICS INC | 81728A207 | COM NEW | 803,425 | $23,893,860 | dollars as filed | |
| ABSCI CORPORATION | 00091E109 | COM | 2,134,803 | $22,991,828 | dollars as filed | |
| DISC MEDICINE INC COM | 254604101 | Stock | 349,657 | $22,888,547 | dollars as filed | |
| ARCUS BIOSCIENCES INC | 03969F109 | COM | 844,816 | $21,821,597 | dollars as filed | |
| GENERATE BIOMEDICINES INC | 370920100 | COMMON STOCK | 1,423,602 | $21,382,502 | dollars as filed | |
| TAYSHA GENE THERAPIES INC | 877619106 | COMMON STOCK | 4,004,756 | $19,503,162 | dollars as filed | |
| AKTIS ONCOLOGY INC | 01021M104 | COMMON STOCK | 996,351 | $19,398,954 | dollars as filed | |
| JADE BIOSCIENCES INC | 008064206 | COM NEW | 1,230,426 | $17,287,485 | dollars as filed | |
| DBV TECHNOLOGIES S A | 23306J309 | SPONSORED ADS | 1,461,425 | $17,186,358 | dollars as filed | |
| FIRST TRACKS BIOTHERAPEUTICS | 337185102 | ORD SHS *A* | 472,932 | $16,760,710 | dollars as filed | |
| PARABILIS MEDICINES INC COM | 698955101 | Stock | 500,000 | $16,145,000 | dollars as filed | |
| TECTONIC THERAPEUTIC INC | 878972108 | COMMON STOCK | 607,788 | $14,155,383 | dollars as filed | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 211,267 | $13,924,608 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 370,208 | $13,768,036 | dollars as filed | |
| CYTOMX THERAPEUTICS INC | 23284F105 | COMMON STOCK | 4,975,826 | $13,534,247 | dollars as filed | |
| DYNE THERAPEUTICS INC COM | 26818M108 | Stock | 813,449 | $13,104,663 | dollars as filed | |
| SCRIBE THERAPEUTIC COM | 811033109 | COM | 688,691 | $12,675,358 | dollars as filed | |
| FREENOME INC | 35661P100 | COMMON STOCK | 794,908 | $12,519,801 | dollars as filed | |
| MAPLIGHT THERAPEUTICS INC | 56565P103 | COMMON STOCK | 1,166,763 | $11,889,315 | dollars as filed | |
| BIONTECH SE SPONSORED ADS | 09075V102 | ADR | 119,743 | $11,770,737 | dollars as filed | |
| SERA PROGNOSTICS INC | 81749D107 | CMN | 5,498,170 | $11,491,175 | dollars as filed | |
| EVOMMUNE INC | 30054Y107 | COMMON STOCK | 1,234,794 | $10,199,398 | dollars as filed | |
| INTELLIA THERAPEUTICS INC | 45826J105 | COM | 829,053 | $9,998,379 | dollars as filed | |
| AVALYN PHARMA INC | 05348Y105 | COMMON STOCK | 350,000 | $9,971,500 | dollars as filed | |
| AVALO THERAPEUTICS INC | 05338F306 | COMMON STOCK | 550,000 | $8,431,500 | dollars as filed | |
| TANGO THERAPEUTICS INC | 87583X109 | COM | 333,333 | $8,316,658 | dollars as filed | |
| LB PHARMACEUTICALS INC | 50180M108 | COMMON STOCK | 200,000 | $7,676,000 | dollars as filed | |
| PROTARA THERAPEUTICS INC | 74365U107 | COM STK | 1,843,795 | $5,623,575 | dollars as filed | |
| CERUS CORP | 157085101 | COM | 2,333,155 | $5,552,909 | dollars as filed | |
| VTV THERAPEUTICS INC | 918385204 | CL A NEW | 148,314 | $4,574,004 | dollars as filed | |
| Q32 BIO INC | 746964105 | Common Stock | 547,945 | $4,531,505 | dollars as filed | |
| EIKON THERAPEUTICS INC | 282564103 | COMMON STOCK | 555,555 | $4,466,662 | dollars as filed | |
| IMMUNOME INC | 45257U108 | COM | 55,306 | $1,189,632 | dollars as filed | |
| SANA BIOTECHNOLOGY INC | 799566104 | COM | 310,483 | $905,058 | dollars as filed | |
| Tscan Therapeutics Inc | 89854M101 | COM | 2,784,792 | $875,817 | dollars as filed | |
| ALIGOS THERAPEUTICS INC | 01626L204 | COM NEW | 83,055 | $467,600 | dollars as filed | |
| SKYE BIOSCIENCE INC COM | 83086J309 | Stock | 196,905 | $317,017 | dollars as filed | |
| TYRA BIOSCIENCES INC | 90240B106 | COMMON STOCK | 10,607 | $231,975 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001104659-26-128308 | this filing | 2026-11-16 |